TAG:
laboratory executive
AACC Convention Exhibits Point To New Lab Trends
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: This year the interesting trend at the AACC’s exhibit hall was modular laboratory automation. That’s a big change from the total laboratory automation solutions touted in past years. But watch out! The economics of this equipment have yet to be validated. It was also clea…
Blunt Talk From HMO Blue’s Ancillary Contracts Manager
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: By now, most clinical laboratory executives and pathologists have discovered a new fact of life: provider status with managed care organizations is a critical success factor. Without provider status, the laboratory is denied access to patients and the reimbursement associated…
AccuMed, AutoCyte, Cytyc, MorphoMetrix, Neuromedical, NeoPath
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
Automated Cytology Update As predicted by THE DARK REPORT, the field of automated cytology has become a boiling pot, filled with controversy and change. Profits are meager. As we expected, the major issue revolves around the cost of this enhanced technology versus the measurable…
Expect ISO 9000 To Alter Clinical Lab Management
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: Perceptive laboratory executives and pathologists should welcome the impending arrival of ISO 9000 into the clinical laboratory industry. It promises to solve many problems of laboratory management. The diagnostics industry, responsible for manufacturing instruments and suppl…
“July 6, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
Last week THE DARK REPORT toured the Framingham, Massachusetts laboratory of Genzyme Genetics, the diagnostic testing division of Genzyme Corporation. It is probably the largest genetics-based diagnostics laboratory organization in the United States. The company’s …
Private Consortium Plans To Decode Human Genes
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Five years ago, the only option for mapping was to involve the government. New advancements in technology have lowered costs so radically that now private companies are willing to use their own funds to map the human genome. This brings the day ever closer when genetics-based…
Premier Explains Reasons It Sees Lab As Strategic
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Premier’s strategic alliance with Quest Diagnostics Incorporated represents a fundamental shift in the marketplace for hospital-based clinical laboratory services. This was a project developed by Premier, in response to its evaluation of marketplace trends affecting hospita…
Humana, Inc. Acquired By United Healthcare
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Clinical laboratories will see increased concentration of laboratory purchasing as a result of this merger. The combined company will insure 19.2 million people in 48 states. This transaction confirms that consolidation proceeds in all areas of the healthcare industry, despit…
Premier & Quest Devise New Service Arrangement
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: Pressure is intense for hospital buying consortiums to justify themselves and deliver added savings and services to their members. The recent announcement of a new national contract between Premier and Quest Diagnostics Incorporated demonstrates that both buying groups and la…
New Alliance Is Example Of Coming Paradigm Shift
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: This strategic alliance represents a fundamental shift within the clinical laboratory industry. It is a response to market forces which should not be ignored by laboratory executives and pathologists anywhere in the country. Whether the alliance succeeds or fails, it will lau…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized